Company Long-Term Loans and Borrowings: Praxis Medicines (PRAX)
The market value dynamics of Praxis Precision Medicines (PRAX) demonstrate the 0.00 indicator. Praxis Precision Medicines is recognized as an authoritative visionary in CNS therapy, enjoying deep trust from the medical community. The business relies on large-scale investments in the development of small molecules to combat epilepsy. The exclusivity of its positions is ensured by strict FDA requirements and patent protection, making the entry of new players into this segment virtually impossible.
Praxis Medicines (PRAX) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Praxis Precision Medicines|PRAX - Long-Term Debt to Capital|Short-Term Debt to Capital Praxis Corp|PRAX - Company Total Debt|Debt to Book Value Ratio Praxis Precision Medicines|PRAX - Company Long-Term Debts|Short-Term Debt Volume Praxis Precision Medicines|Interim Coverage Ratio praxismedicines.com
- earnings and market multiples details:
Fundamental company valuation:praxismedicines.com - PRAX
To protect capital from volatility, it is crucial for investors to assess the total volume of liabilities with a maturity of over one year, which determines the issuer's financial stability. The clinical research outsourcing strategy of Praxis Precision Medicines (PRAX) minimizes capital expenditures; therefore, analyzing the trend of the business's long-term debt allows for the identification of hidden credit load risks and an assessment of the portfolio's margin of safety.
Who Praxis Precision Medicines competes with
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|vikingtherapeutics.com - Long-Term Liabilities|Company Long-Term Debt Supernus (SUPN)|CPRX (Catalyst Pharma) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DNLI (Denali Therapeutics Inc)|Company Long-Term Debts Harmony Corp HRMY|BHVN: Company Long-Term Liabilities|AMLX (amylyx.com) - Company Long-Term Indebtedness|TRVI: Company Long-Term Debts|AVXL - Long-Term Debt Volume|Company Long-Term Debt CeriBell Corp|prothena.com (PRTA) - Long-Term Debt Volume|Company Long-Term Liabilities ALEC (Alector, Inc.)|ANNX (annexonbio.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Omeros OMER|NGNE (Neurogene Inc) - Long-Term Liabilities|ACIU - Company Long-Term Debt|Company Long-Term Loans and Borrowings VYGR (Voyager Corp)|NMRA: Company Long-Term Debts|Long-Term Debt scilexholding.com (SCLX)|TVGN (Tevogen Bio) - Company Long-Term Debts|Company Long-Term Liabilities Alpha Cognition Corp (ACOG)|Company Long-Term Debts CGTX|Long-Term Debt Volume Inhibikase Pharma|Company Long-Term Debt Cassava Sciences, Inc. SAVA|Long-Term Debt Volume Assertio Holdings (ASRT)|Coya - Company Long-Term Debts|Long-Term Debt Volume Vistagen Therapeutics VTGN|ovidrx.com (OVID) - Company Long-Term Debt|Long-Term Debt Acumen Pharmaceuticals, Inc (ABOS)|Company Long-Term Debt CervoMed Inc.|Company Long-Term Indebtedness ATHE (Alterity Therapeutics Ltd)|Company Long-Term Liabilities CLNN (Clene Inc.)|PEPG (pepgen.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Jupiter Neurosciences Inc JUNS|RLMD - Company Long-Term Liabilities|Annovis Bio, Inc. - Company Long-Term Debts|Long-Term Debt Grace Therapeutics, Inc.|AIFF: Company Long-Term Debts|Company Long-Term Indebtedness KLTO|NRSN (NeuroSense Therapeutics Ltd) - Company Long-Term Debts|Reviva Pharmaceuticals, Inc. (RVPH) - Long-Term Debt Volume|Company Long-Term Debts MTVA|Company Long-Term Liabilities neuraxis.com NRXS|Company Long-Term Debts HSDT (Helius Medical Technologies)|Long-Term Debt Volume Passage Bio Inc. (PASG)|NEUP - Company Long-Term Debt|NERV (Minerva) - Company Long-Term Indebtedness|ATHA: Company Long-Term Debts|Long-Term Debt addextherapeutics.com (ADXN)|Company Long-Term Debt Alzamend Neuro Inc.|Cyclerion (CYCN) - Long-Term Debt Volume|Company Long-Term Debt Protagenic Therapeutics (PTIX)|KTTA: Long-Term Liabilities|Company Long-Term Debt Cortigent CRGT|Company Long-Term Loans and Borrowings ATXI|BrainStorm Cell Therapeutics - Company Long-Term Debts|CARA - Company Long-Term Debts|CHRO (Chromocell Therapeutics Corporation) - Company Long-Term Liabilities|Company Long-Term Indebtedness ELYM|Company Long-Term Debt Intra-Cellular Therapies Inc.|Company Long-Term Indebtedness LBPH (longboardpharma.com)|Company Long-Term Debts MRNS|NKGN - Long-Term Debt|NeuroBo - Company Long-Term Liabilities|Company Long-Term Debts Sage Therapeutics Inc SAGE|SNPX - Company Long-Term Debt|Company Long-Term Loans and Borrowings TRVN (trevena.com)|vigilneuro.com (VIGL) - Company Long-Term Debt|Long-Term Debt Anew Medical Inc. (WENA)|Company Long-Term Debt Cerevel